Hinge Health, Inc.·4

May 12, 4:13 PM ET

Budge James 4

Research Summary

AI-generated summary

Updated

Hinge Health (HNGE) CFO James Budge Sells Shares

What Happened James Budge, Chief Financial Officer of Hinge Health (HNGE), sold a total of 5,906 shares in open-market transactions on May 11, 2026, generating roughly $323,759 in proceeds. The filing reports 4,706 shares sold at a weighted average price of $54.65 for $257,186 and 1,200 shares sold at a weighted average price of $55.48 for $66,573. These transactions were sales (S), not purchases.

Key Details

  • Transaction date: May 11, 2026.
  • Report filed: May 12, 2026 (no late filing indicated).
  • Breakdown: 4,706 shares @ $54.65 (proceeds $257,186); 1,200 shares @ $55.48 (proceeds $66,573); total ~5,906 shares for ~$323,759.
  • Footnotes: Sales were made pursuant to a Rule 10b5-1 trading plan adopted June 12, 2025 (F1). Reported weighted-average prices have per-line price ranges: first sale line ranged $54.14–$55.13 (F2); second sale line ranged $55.18–$56.05 (F3). The reporting person offers to provide the full breakdown of shares sold at each separate price upon request to the SEC, issuer, or stockholders.
  • Shares owned after the transaction: not specified in the provided filing.

Context These were routine sales executed under a pre-established 10b5-1 trading plan, which is commonly used to automate insider trades and reduce questions about timing. Sales do not necessarily signal a change in view about the company; purchases are generally more indicative of insider bullishness.